These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8567223)

  • 21. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment gap in the use of lipid-lowering drug therapy in diabetes: a population-based study.
    James P; Tan HH; MacAlpine R; Brennan G; Emslie-Smith A; Morris AD
    Diabet Med; 2004 Oct; 21(10):1108-12. PubMed ID: 15384958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of short-term sulodexide treatment on peripheral vascular disease clinical manifestations.
    Caramelli L; Mirchioni R; Carini A
    Riv Eur Sci Med Farmacol; 1988 Feb; 10(1):55-8. PubMed ID: 3079198
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy].
    Berger M
    Z Kardiol; 1998; 87 Suppl 2():210-3. PubMed ID: 9827485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A double blind study of the new hypolipidemic agent pirozadil (722-D) using patients with ischemic heart disease (author's transl)].
    Cadierno Carpintero M; Emeterio Reig E; Soler Masana JM
    Med Clin (Barc); 1982 May; 78(9):386-9. PubMed ID: 7047927
    [No Abstract]   [Full Text] [Related]  

  • 26. [What should be the role of antilipemic agents in the control of hypercholesterolemia in elderly persons?].
    Champoux N; Latour J
    Union Med Can; 1994 Feb; 123(2):91-4. PubMed ID: 8203037
    [No Abstract]   [Full Text] [Related]  

  • 27. [CHAOS [Cambridge Heart Antioxidant Study]].
    Niki E; Noguchi N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():448-51. PubMed ID: 11347112
    [No Abstract]   [Full Text] [Related]  

  • 28. Does lipid-lowering therapy promote regression of coronary atheroma?
    Leng GC; Fowkes FG
    Br J Gen Pract; 1994 Jan; 44(378):3-4. PubMed ID: 8312035
    [No Abstract]   [Full Text] [Related]  

  • 29. Secondary prevention of coronary disease with lipid-lowering drugs.
    Lancet; 1989 Mar; 1(8636):473-4. PubMed ID: 2563844
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of low cholesterol with aggression.
    Peer DA; Stoukides CA
    Ann Pharmacother; 1992 Jun; 26(6):785-6. PubMed ID: 1611162
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comment on N. Worm: Nutrition and coronary heart disease: how important is diet?].
    Maes HJ
    Versicherungsmedizin; 1995 Dec; 47(6):231-3. PubMed ID: 8571502
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative study of the action of hypolipemic and antioxidant drugs in ischemic heart disease].
    Kalmykova VI; Nikitina EK; Bezzubov AA
    Sov Med; 1986; (3):81-4. PubMed ID: 3520867
    [No Abstract]   [Full Text] [Related]  

  • 33. [Undesirable effects of hypolipemic drugs].
    Schettler G
    Clin Ter; 1980 Mar; 92(5):457-67. PubMed ID: 7449323
    [No Abstract]   [Full Text] [Related]  

  • 34. Gemfibrozil and coronary heart disease.
    N Engl J Med; 1988 May; 318(19):1274-5. PubMed ID: 3163103
    [No Abstract]   [Full Text] [Related]  

  • 35. Treadmill testing and selection of hypercholesterolemic patients for treatment.
    Vine DL
    Kans Med; 1989 Nov; 90(11):323-4. PubMed ID: 2687549
    [No Abstract]   [Full Text] [Related]  

  • 36. Heart Protection Study.
    Trewby P
    Lancet; 2003 Feb; 361(9356):530; author reply 530. PubMed ID: 12583970
    [No Abstract]   [Full Text] [Related]  

  • 37. Secondary prevention of coronary heart disease. Secondary prevention programmes may reduce overall mortality in high risk patients.
    Tang JL; Tam W
    BMJ; 2002 Mar; 324(7337):611. PubMed ID: 11887885
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical trial of a new drug for the treatment of atherosclerosis: pirozadil (722-D) (author's transl)].
    Marín Plaza R; Díaz González JM; Varela de Seijas JR
    Med Clin (Barc); 1982 May; 78(10):427-32. PubMed ID: 7047924
    [No Abstract]   [Full Text] [Related]  

  • 39. Cholesterol lowering--the sense and the sensationalism.
    Ball M; Mann J
    N Z Med J; 1992 Jul; 105(938):283-4. PubMed ID: 1386655
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug treatment of hypercholesterolaemia. Determine cardiac risk.
    Capps N; Hartland A
    BMJ; 1994 Jan; 308(6920):56-7. PubMed ID: 8298358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.